Unexplained fetal death
DOI:
https://doi.org/10.18597/rcog.584Keywords:
unexplained fetal death, stillbirth, fetal loss, risk factors, maternal disease, thrombophilia, umbilical cord, congenital infectionsAbstract
Reports in the literature demonstrate that the percentage of unexplained fetal death occurs from 21 to 50%. Unexplained fetal death is defined as the demise of the fetus occurring at gestational age beyond 20 weeks or fetal weight of more than 500 g, with a thorough autopsy of the fetus and histology examination of the umbilical cord, placenta, and membranes, fails to demonstrate the cause of death.
The following factors are associated with unexplained fetal death, maternal age beyond 35 years, overweight, ten years or less in a school, smoking, low socioeconomic status class and others.
Fetal deaths are related to maternal medical disease, thrombophilia, umbilical cord accidents, cytogenetics, metabolic and congenital infections.
The following is a review of the main aspects of unexplained fetal death.
Author Biographies
Janer Sepúlveda
Eliana Maribel Quintero
References
Froen JF, Arnestad M, Frey K, Vege A, Saugstad OD, Stray-Pedersen B. Risk factors for sudden intrauterine unexplained death: epidemiologic characteristics of singleton cases in Oslo, Norway, 1986-1995. Am J Obstet Gynecol 2001;184:694-702.
Incerpi MH, Miller DA, Samadi R, Settlage RH, Goodwin TM. Stillbirth evaluation: what tests are needed? Am J Obstet Gynecol 1998;178:1121-5.
Cnattingius S, Stephansson O. The epidemiology of stillbirth. Semin Perinatol 2002;26:25-30.
Cnattingius S, Forman MR, Berendes HW, Italo L. Delayed childbearing and risk of adverse perinatal outcome. A population-based study. JAMA 1992;268:886-90.
Fretts RC, Schmittdiel J, McLean FH, Usher RH, Goldman MB. Increased maternal age and the risk of fetal death. N Engl J Med 1995;333:953-7.
Fretts RC, Usher RH. Causes of fetal death in women of advanced maternal age. Obstet Gynecol 1997;89:40-5.
Raymond EG, Cnattingius S, Kiely JL. Effects of maternal age, parity and smoking on the risk of stillbirth. Br J Obstet Gynaecol 1994;101:301-6.
Sims MA, Collins KA. Fetal death. A 10-year retrospective study. Am J Forensic Med Pathol 2001;22:261-5.
Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ 2000;320:1708-12.
Olausson PO, Cnattingius S, Haglund B. Teenage pregnancies and risk of late fetal death and infant mortality. Br J Obstet Gynaecol 1999;106:116-21.
Huang DY, Usher RH, Kramer MS, Yang H, Morin L, Fretts RC. Determinants of unexplained antepartum fetal deaths. Obstet Gynecol 2000;95:215-21.
Cnattingius S, Bergstrom R, Lipworth L, Kramer MS. Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med 1998;338:147-52.
Wolfe H. High prepregnancy body-mass index - a maternal-fetal risk factor honor. N Engl J Med 1998;338:191-2.
Stephansson O, Dickman PW, Johansson A, Cnattingius S. Maternal weight, pregnancy weight gain, and the risk of antepartum stillbirth. Am J Obstet Gynecol 2001;184:463-9.
Fifer WP, Myers MM. Sudden fetal and infant deaths: shared characteristics and distinctive features. Semin Perinatol 2002;26:89-96.
Yudkin PL, Wood L, Redman CW. Risk of unexplained stillbirth at different gestational ages. Lancet 1987:1:1192-4.
King WD, Dodds L, Allen AC. Relation between stillbirth and specific chlorination by-products in public water supplies. Environ Health Perspect 2000;108:883-6.
Cnattingius S, Berendes HW, Forman MR. Do delayed childbearers face increased risks of adverse pregnancy outcomes after the first birth? Obstet Gynecol 1993;81:512-6.
Stephansson O, Dickman PW, Johansson A, Cnattingius S. Maternal hemoglobin concentration during pregnancy and risk of stillbirth. JAMA 2000;284:2611-7.
Pharoah PO, Ady Y. Consequences of in-utero death in a twin pregnancy. Lancet 2000;355:1597-602.
Wisborg K, Kesmodel U, Bech BH, Hedegaard M, Henriksen TB. Maternal consumption of coffee during pregnancy and stillbirth and infant death in first year of life: prospective study. BMJ 2003;326:420.
Smith GC, Pell JP, Dobbie R. Caesarean section and risk of unexplained stillbirth in subsequent pregnancy. Lancet 2003:362:1779-84.
Simpson LL. Maternal medical disease: risk of antepartum fetal death. Semin Perinatol 2002;26:42-50.
Martin JN Jr, Rinehart BK, May WL, Magann EF, Terrone DA, Blake PG. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol 1999;180:1373-84.
Visser W, Wallenburg HC. Temporising management of severe preeclampsia with and without the HELLP syndrome. Br J Obstet Gynaecol 1995;102:111-7.
Brazetol WF, Grover S, Donnenfeld AE. Unexplained elevated maternal serum alpha fetoprotein levels and perinatal outcome in an urban clinic population. Am J Obstet Gynecol 1994;171:1030-5.
Krause TG, Christens P, Wohlfahrt J, Lei U, Westergaard T, Nergaard-Pedersen B, et al. Second trimester maternal serum alpha-fetoprotein and risk of adverse pregnancy outcome. Obstet Gynecol 2001;97:277-82.
Cundy T, Gamble G, Townend K, Henley PG, MacPherson P, Roberts AB. Perinatal mortality in Type 2 diabetes mellitus. Diabet Med 2000;17:33-9.
Lockshin MD. Antiphospholipid antibody. Babies, blood clots, biology. JAMA 1997;277:1549-51.
Oshiro BT, Silver RM, Scott JR, Yu H, Brand DW. Antiphospholipid antibodies and fetal death. Obstet Gynecol 1996;87:489-93.
Cunningham FG, Cox SM, Harstad TW, Mason RA, Pritchard JA. Chronic renal disease and pregnancy outcome. Am J Obstet Gynecol 1990;163:453-9.
Leung AS, Millar LK, Koonings PP, Montoro M, Mestman JH. Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol 1993;81:349-53.
Many A, Elad R, Yaron Y, Eldor A, Lessing JB, Kupferminc MJ. Third-trimester unexplained intrauterine fetal death is associated with inherited thrombophilia. Obstet Gynecol 2002;99:684-7.
Saade GR, McLintock C. Inherited thrombophilia and stillbirth. Semin Perinatol 2002;26:51-69.
Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003;361:901-8.
Perry SL, Ortel TL. Clinical and laboratory evaluation of thrombophilia. Clin Chest Med 2003;24:153-70.
Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001;344:1222-31.
Martinelli I, Taioli E, Cetin I, Marinoni A, Gerosa S, Villa MV, et al. Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med 2000;343:1015-8.
Roberts D, Schwartz RS. Clotting and hemorrhage in the placenta a delicate balance. N Engl J Med 2002;347:57-9.
Preston FE, Rosendaal FR, Walker ID, Briet E, Berntorp E, Conard J, et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348:913-6.
Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340:9-13.
Gebhardt GS, Hall DR. Inherited and acquired thrombophilias and poor pregnancy outcome: should we be treating with heparin? Curr Opin Obstet Gynecol 2003;15:501-6.
Walker MC, Ferguson SE, Allen VM. Heparin for pregnant women with acquired or inherited thrombophilias (Cochrane Review). The Cochrane Library, Issue 4, 2004.
Sibai BM. Thrombophilias and adverse outcomes of pregnancy— what should a clinician do? N Engl J Med 1999;340:50-2.
Greer IA. The challenge of thrombophilia in maternal-fetal medicine. N Engl J Med 2000;342:424-5.
Alonso A, Soto I, Urgelles MF, Corte JR, Rodriguez MJ, Pinto CR. Acquired and inherited thrombophilia in women with unexplained fetal losses. Am J Obstet Gynecol 2002;187:1337-42.
Jilma B, Kamath S, Lip GYH. ABC of antithrombotic therapy. Antithrombotic therapy in special circumstances. II-In children, thrombophilia, and miscellaneous conditions. BMJ 2003;326:93-6.
Collins JH. Umbilical cord accidents: human studies. Semin Perinatol 2002;26:79-82.
Lee W, Lee VL, Kirk JS, Sloan CT, Smith RS, Comstock CH. Vasa previa: prenatal diagnosis, natural evolution and clinical outcome. Obstet Gynecol 2000;95:572-6.
Wapner RJ, Lewis D. Genetics and metabolic causes of stillbirth. Semin Perinatol 2002;26:70-4.
Goldenberg RL, Thompson C. The infectious origins of stillbirth. Am J Obstet Gynecol 2003;189:861-73.
How to Cite
Downloads
Downloads
Published
Issue
Section
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
